DNTH R&D to Revenue
Dianthus Therapeutics Inc · R&D to Revenue
DNTH R&D to Revenue
Latest reported6397.63%period ending
DNTH Quarterly R&D/Revenue (0.00% → 6397.63%)
Latest values, visible window
High-resolution chart · PNG
DNTH r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 6,397.6347% | |
| 7,457.4514% | |
| 21,089.7887% | |
| 8,204.2927% | |
| 13,601.5544% | |
| 2,321.8401% | |
| 1,991.9306% | |
| 1,176.0589% | |
| 969.941% | |
| 1,496.3387% | |
| 1,921.4442% | |
| 861.4719% | |
| 1,058.1011% | |
| 1,228.3613% | |
| 836.6809% | |
| 615.3453% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |